申请人:Medicure International Inc.
公开号:US20040186077A1
公开(公告)日:2004-09-23
The invention teaches compound of general formula:
1
Wherein:
R
1
is selected from H and CH
3
, and R
2
is selected from H and OH, or R
1
and R
2
together form an optionally substituted phenyl ring which is fused to the pyridine ring; and
R
3
is selected from H, CH
3
, CH
2
OH and
2
R
4
is selected from H, CH
3
, CH
2
OH,
3
R
5
is selected from H, phenyl, halogen-substituted phenyl and
4
Wherein R
6
and R
7
are each independently selected from H, Na
+
, K
+
, alkyl and optionally substituted aryl, and X and Y are each independently selected from H, OH and F, or at least one of X and Y is an heteroatom and together with R
3
forms a bridge with the proviso that R
4
is
5
and N-oxides thereof, and biologically acceptable salts thereof, related compounds, related pharmaceutical compositions, and methods for treating various disorders using such compositions.
发明教授了一般式的化合物:
其中:
R1选自H和CH3,R2选自H和OH,或者R1和R2共同形成一个可选择取代的苯环,与吡啶环融合;
R3选自H、CH3、CH2OH和2,R4选自H、CH3、CH2OH、3,R5选自H、苯基、卤代苯基和4。
其中R6和R7各自独立选自H、Na+、K+、烷基和可选择取代芳基,X和Y各自独立选自H、OH和F,或者X和Y中至少一个是杂原子,并与R3一起形成桥梁,但R4是5和其N-氧化物,以及其生物学上可接受的盐,相关化合物、相关药物组合物,以及使用这些组合物治疗各种疾病的方法。